Extended Data Fig. 2: Comparative analysis of SARS-CoV-2 sVNT and indirect RBD ELISA with monoclonal antibodies. | Nature Biotechnology

Extended Data Fig. 2: Comparative analysis of SARS-CoV-2 sVNT and indirect RBD ELISA with monoclonal antibodies.

From: A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction

Extended Data Fig. 2: Comparative analysis of SARS-CoV-2 sVNT and indirect RBD ELISA with monoclonal antibodies.The alternative text for this image may have been generated using AI.

The species origin of monoclonal antibodies are as follows: 4 from mouse (a, b); 4 from rabbit (c, d); 3 from llama (e, f); and 4 from human (g, h). For each set of sera, indirect RBD-binding ELISA (a, c, e, g) and RBD-blocking sVNT (b, d, f, g) were conducted side-by-side. For the two human NAbs, a synergy comparative study was also conducted (i).

Back to article page